Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II).
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2018
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 02 Apr 2012 Actual patient number is 6 according to ClinicalTrials.gov.
- 02 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Apr 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.